# Merck on The No Agenda Show

Merck comes up in 77 chapters across 74 episodes of The No Agenda Show, from September 2008 to February 2024.

- **Chapters:** 77
- **Episodes:** 74
- **Discussed:** September 2008 – February 2024
- **Related topics:** [Gardasil](https://search.noagendashow.net/topic/gardasil.md), [Hpv](https://search.noagendashow.net/topic/hpv.md), [Ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [Cdc](https://search.noagendashow.net/topic/cdc.md), [Pfizer](https://search.noagendashow.net/topic/pfizer.md), [Fda](https://search.noagendashow.net/topic/fda.md), [Mmr Vaccine](https://search.noagendashow.net/topic/mmr-vaccine.md), [Cervical Cancer](https://search.noagendashow.net/topic/cervical-cancer.md), [Vaccine](https://search.noagendashow.net/topic/vaccine.md), [Hpv Vaccine](https://search.noagendashow.net/topic/hpv-vaccine.md)

## Chapters 1–20 of 77

### Pharma Media Capture, Tucker Carlson, News Advertising

- **Episode:** [1631: Pulling a Johnson](https://search.noagendashow.net/episode/1631-pulling-a-johnson.md)
- **Published:** 2024-02-04
- **Time:** 1:39:28–1:43:50
- **Transcript:** https://search.noagendashow.net/episode/1631-pulling-a-johnson/chapter/pharma-media-capture-tucker-carlson-news-advertising.md

Tucker Carlson interviews a functional medicine doctor who claims pharmaceutical companies buy TV advertising not to sell drugs, but to "buy off" news networks and prevent investigative reporting. The hosts play a clip from 2011 where they made the same observation, noting that the U.S. is one of only two countries that allow direct-to-consumer prescription drug ads. They argue the media has been "captured" by the medical-industrial complex.

Keywords: [big pharma](https://search.noagendashow.net/topic/big-pharma.md), [tucker carlson](https://search.noagendashow.net/topic/tucker-carlson.md), [glaxosmithkline](https://search.noagendashow.net/topic/glaxosmithkline.md), [merck](https://search.noagendashow.net/topic/merck.md), [advertising](https://search.noagendashow.net/topic/advertising.md)

### Moderna and Merck, Melanoma Vaccine, mRNA Technology

- **Episode:** [1562: Tink Tank](https://search.noagendashow.net/episode/1562-tink-tank.md)
- **Published:** 2023-06-08
- **Time:** 1:13:50–1:18:30
- **Transcript:** https://search.noagendashow.net/episode/1562-tink-tank/chapter/moderna-and-merck-melanoma-vaccine-mrna-technology.md

Moderna and Merck released trial results for a personalized mRNA cancer vaccine used in conjunction with the immunotherapy drug Keytruda. The combination therapy reportedly showed a 65% reduction in the recurrence of stage 3 and 4 melanoma. Unlike traditional vaccines, this treatment is customized to the genetic sequence of an individual patient's tumor.

Keywords: [moderna](https://search.noagendashow.net/topic/moderna.md), [merck](https://search.noagendashow.net/topic/merck.md), [melanoma](https://search.noagendashow.net/topic/melanoma.md), [mrna](https://search.noagendashow.net/topic/mrna.md), keytruda

### Johnson & Johnson Restructuring, Talcum Powder Lawsuits and Merck Failures

- **Episode:** [1527: Grip & Grin](https://search.noagendashow.net/episode/1527-grip-grin.md)
- **Published:** 2023-02-05
- **Time:** 1:28:13–1:29:56
- **Transcript:** https://search.noagendashow.net/episode/1527-grip-grin/chapter/johnson-johnson-restructuring-talcum-powder-lawsuits-and-merck-failures.md

Johnson & Johnson is undergoing a global overhaul as it faces massive legal liabilities from talcum powder and asbestos lawsuits. Meanwhile, Merck's COVID-19 drug is reportedly linked to viral mutations, potentially putting the company at a disadvantage against competitors like Pfizer. These financial pressures are forcing major shifts in the pharmaceutical industry.

Keywords: [johnson & johnson](https://search.noagendashow.net/topic/johnson-johnson.md), [merck](https://search.noagendashow.net/topic/merck.md), talcum powder, [asbestos](https://search.noagendashow.net/topic/asbestos.md), [paxlovid](https://search.noagendashow.net/topic/paxlovid.md), [lawsuits](https://search.noagendashow.net/topic/lawsuits.md)

### mRNA Technology Expansion into Cancer and Flu Treatments

- **Episode:** [1512: Cash is Criminal](https://search.noagendashow.net/episode/1512-cash-is-criminal.md)
- **Published:** 2022-12-15
- **Time:** 2:12:19–2:15:09
- **Transcript:** https://search.noagendashow.net/episode/1512-cash-is-criminal/chapter/mrna-technology-expansion-into-cancer-and-flu-treatments.md

Moderna and Merck announced promising results from a small study using mRNA technology to treat melanoma, claiming it significantly lowers the risk of relapse. Scientists are also exploring mRNA for flu vaccines and using base-editing gene technology to treat leukemia in teenagers. Critics remain skeptical of the "platform" approach, fearing long-term side effects from widespread mRNA application.

Keywords: [moderna](https://search.noagendashow.net/topic/moderna.md), [merck](https://search.noagendashow.net/topic/merck.md), [melanoma](https://search.noagendashow.net/topic/melanoma.md), [mrna](https://search.noagendashow.net/topic/mrna.md), [gene editing](https://search.noagendashow.net/topic/gene-editing.md)

### Paxlovid Rebound, Alberta Unknown Deaths, Vaccine Skepticism

- **Episode:** [1473: Meth Raging](https://search.noagendashow.net/episode/1473-meth-raging.md)
- **Published:** 2022-07-31
- **Time:** 1:51:42–1:57:33
- **Transcript:** https://search.noagendashow.net/episode/1473-meth-raging/chapter/paxlovid-rebound-alberta-unknown-deaths-vaccine-skepticism.md

President Biden experiences a "rebound" COVID-19 infection after taking Pfizer's Paxlovid, a phenomenon some producers suggest is more common than reported. In Alberta, Canada, "unknown causes" became the leading cause of death in 2021, surpassing dementia and COVID-19. The hosts criticize the media for failing to investigate potential links between these trends and mass vaccination campaigns.

Keywords: [paxlovid](https://search.noagendashow.net/topic/paxlovid.md), [joe biden](https://search.noagendashow.net/topic/joe-biden.md), [alberta](https://search.noagendashow.net/topic/alberta.md), unknown causes, [vaccine](https://search.noagendashow.net/topic/vaccine.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [merck](https://search.noagendashow.net/topic/merck.md)

### Agency Capture, CDC and Merck Allegations

- **Episode:** [1439: COVID Retrospective](https://search.noagendashow.net/episode/1439-covid-retrospective.md)
- **Published:** 2022-04-03
- **Time:** 2:04:27–2:07:52
- **Transcript:** https://search.noagendashow.net/episode/1439-covid-retrospective/chapter/agency-capture-cdc-and-merck-allegations.md

A report discusses the concept of "agency capture," specifically alleging that the CDC has become a "sock puppet" for the vaccine industry. The discussion focuses on former CDC head Julie Gerberding, who later became president of Merck's vaccine division. Allegations include the silencing of whistleblowers regarding the MMR vaccine and the approval of products like Gardasil and the chickenpox vaccine.

Keywords: agency capture, [cdc](https://search.noagendashow.net/topic/cdc.md), [merck](https://search.noagendashow.net/topic/merck.md), [julie gerberding](https://search.noagendashow.net/topic/julie-gerberding.md), [mmr vaccine](https://search.noagendashow.net/topic/mmr-vaccine.md), [autism](https://search.noagendashow.net/topic/autism.md)

### Merck COVID Pill, Ivermectin Testing Conflict

- **Episode:** [1411: Norgay](https://search.noagendashow.net/episode/1411-norgay.md)
- **Published:** 2021-12-26
- **Time:** 1:27:55–1:31:13
- **Transcript:** https://search.noagendashow.net/episode/1411-norgay/chapter/merck-covid-pill-ivermectin-testing-conflict.md

The FDA authorized a COVID-19 pill from Merck, though it is only recommended when Pfizer's more effective treatment is unavailable. Merck has faced criticism for not pursuing Ivermectin as a COVID treatment, despite a Japanese university offering to conduct tests on the drug.

Keywords: [merck](https://search.noagendashow.net/topic/merck.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [fda](https://search.noagendashow.net/topic/fda.md), [monoclonal antibodies](https://search.noagendashow.net/topic/monoclonal-antibodies.md)

### Merck Molnupiravir, FDA Advisory Committee Vote

- **Episode:** [1404: Flub Meister](https://search.noagendashow.net/episode/1404-flub-meister.md)
- **Published:** 2021-12-02
- **Time:** 32:14–34:16
- **Transcript:** https://search.noagendashow.net/episode/1404-flub-meister/chapter/merck-molnupiravir-fda-advisory-committee-vote.md

An FDA advisory committee voted 13-10 to recommend EUA for Merck's antiviral pill, Molnupiravir, despite concerns over its 34% efficacy and potential risks during pregnancy. The discussion contrasts the approval of this expensive pill with the suppression of cheaper alternatives like ivermectin.

Keywords: [merck](https://search.noagendashow.net/topic/merck.md), [molnupiravir](https://search.noagendashow.net/topic/molnupiravir.md), [fda](https://search.noagendashow.net/topic/fda.md), [antiviral pill](https://search.noagendashow.net/topic/antiviral-pill.md), pregnancy risks, [ivermectin](https://search.noagendashow.net/topic/ivermectin.md)

### Financial Market Reaction, Post-Thanksgiving Trading, Vaccine Hesitancy

- **Episode:** [1403: In Silico](https://search.noagendashow.net/episode/1403-in-silico.md)
- **Published:** 2021-11-28
- **Time:** 1:31–3:50
- **Transcript:** https://search.noagendashow.net/episode/1403-in-silico/chapter/financial-market-reaction-post-thanksgiving-trading-vaccine-hesitancy.md

The Dow Jones Industrial Average dropped approximately 1,000 points on the Friday following Thanksgiving, coinciding with the launch of the Omicron narrative. Speculation suggests the timing was optimized for low-volume trading days to maximize market impact while pharmaceutical companies like Pfizer and Merck prepare new therapeutics.

Keywords: [dow jones](https://search.noagendashow.net/topic/dow-jones.md), [thanksgiving](https://search.noagendashow.net/topic/thanksgiving.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [merck](https://search.noagendashow.net/topic/merck.md), [vaccine hesitancy](https://search.noagendashow.net/topic/vaccine-hesitancy.md)

### Smallpox Vials Discovery, Merck Facility Investigation

- **Episode:** [1400: The Learning Curve](https://search.noagendashow.net/episode/1400-the-learning-curve.md)
- **Published:** 2021-11-18
- **Time:** 1:11:15–1:15:15
- **Transcript:** https://search.noagendashow.net/episode/1400-the-learning-curve/chapter/smallpox-vials-discovery-merck-facility-investigation.md

The FBI and CDC investigate the discovery of several vials labeled "smallpox" at a Merck facility in Montgomery County, Pennsylvania. Smallpox was declared eradicated in 1980 and is officially stored only at the CDC in Atlanta and a lab in Russia. A similar discovery of vials occurred in 2014 at an NIH storage room, raising questions about the security of deadly pathogens.

Keywords: [smallpox](https://search.noagendashow.net/topic/smallpox.md), [merck](https://search.noagendashow.net/topic/merck.md), [cdc](https://search.noagendashow.net/topic/cdc.md), [fbi](https://search.noagendashow.net/topic/fbi.md), [pennsylvania](https://search.noagendashow.net/topic/pennsylvania.md)

### Merck Financial Performance, Antiviral Pill and Molnupiravir

- **Episode:** [1395: Inflation Demon](https://search.noagendashow.net/episode/1395-inflation-demon.md)
- **Published:** 2021-10-31
- **Time:** 55:38–59:31
- **Transcript:** https://search.noagendashow.net/episode/1395-inflation-demon/chapter/merck-financial-performance-antiviral-pill-and-molnupiravir.md

Merck reported a strong fiscal quarter, exceeding expectations by $1 billion, driven by growth in its oncology business and a 68% increase in Gardasil sales. CEO Robert Davis discussed the upcoming launch of Molnupiravir, an oral antiviral pill intended for home use, with an advisory committee meeting scheduled for late November. Merck plans to produce 10 million courses of the drug by the end of the year, with pricing estimated by some analysts at up to $2,000 per course.

Keywords: [merck](https://search.noagendashow.net/topic/merck.md), [molnupiravir](https://search.noagendashow.net/topic/molnupiravir.md), [antiviral pill](https://search.noagendashow.net/topic/antiviral-pill.md), [oncology](https://search.noagendashow.net/topic/oncology.md), [gardasil](https://search.noagendashow.net/topic/gardasil.md)

### Merck Refusal to Study Ivermectin and Nobel Prize Connection

- **Episode:** [1390: No Hugs For You!](https://search.noagendashow.net/episode/1390-no-hugs-for-you.md)
- **Published:** 2021-10-14
- **Time:** 1:37:19–1:41:21
- **Transcript:** https://search.noagendashow.net/episode/1390-no-hugs-for-you/chapter/merck-refusal-to-study-ivermectin-and-nobel-prize-connection.md

Kitasato University in Japan requested that Merck conduct clinical trials for ivermectin as a COVID-19 treatment, but the company declined. The hosts note that ivermectin's co-discoverer, Satoshi Omura, won the Nobel Prize in 2015. They speculate that Merck's refusal is based on the drug being off-patent and therefore not profitable compared to new proprietary treatments.

Keywords: [merck](https://search.noagendashow.net/topic/merck.md), [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), satoshi omura, [nobel prize](https://search.noagendashow.net/topic/nobel-prize.md), [clinical trials](https://search.noagendashow.net/topic/clinical-trials.md)

### Merck Molnupiravir COVID-19 Treatment and Ivermectin Comparisons

- **Episode:** [1387: Clippers 'n Whittlers](https://search.noagendashow.net/episode/1387-clippers-n-whittlers.md)
- **Published:** 2021-10-03
- **Time:** 8:18–16:47
- **Transcript:** https://search.noagendashow.net/episode/1387-clippers-n-whittlers/chapter/merck-molnupiravir-covid-19-treatment-and-ivermectin-comparisons.md

Merck announced that its experimental antiviral pill, Molnupiravir, reduced COVID-19 hospitalizations and deaths by 50% in clinical trials. The drug's origins are traced back to Emory University research on Venezuelan equine encephalitis virus, leading to its nickname "Merc-mectin" due to Merck's simultaneous dismissal of the cheaper Ivermectin. Financial details reveal a U.S. government procurement agreement for 1.7 million courses at a price of $1.2 billion, equating to roughly $700 per treatment.

Keywords: [merck](https://search.noagendashow.net/topic/merck.md), [molnupiravir](https://search.noagendashow.net/topic/molnupiravir.md), [covid-19](https://search.noagendashow.net/topic/covid-19.md), [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [fda](https://search.noagendashow.net/topic/fda.md)

### William Campbell, Ivermectin and Merck Wokeness

- **Episode:** [1381: Stink Minority](https://search.noagendashow.net/episode/1381-stink-minority.md)
- **Published:** 2021-09-12
- **Time:** 1:45:17–1:50:08
- **Transcript:** https://search.noagendashow.net/episode/1381-stink-minority/chapter/william-campbell-ivermectin-and-merck-wokeness.md

Nobel Prize winner William Campbell, a co-discoverer of Ivermectin, expressed frustration over Merck's public denigration of the drug for COVID-19 use. While Ivermectin is a generic drug derived from Japanese soil, Merck's corporate website now focuses heavily on ESG goals and social justice rather than pharmaceutical innovation. The company's stance against its own historic product is seen as a move to protect newer, more profitable treatments.

Keywords: william campbell, [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [merck](https://search.noagendashow.net/topic/merck.md), [nobel prize](https://search.noagendashow.net/topic/nobel-prize.md), [esg](https://search.noagendashow.net/topic/esg.md)

### Jimmy Kimmel Ivermectin Monologue and Alex Jones

- **Episode:** [1380: TransMoney](https://search.noagendashow.net/episode/1380-transmoney.md)
- **Published:** 2021-09-11
- **Time:** 30:25–33:53
- **Transcript:** https://search.noagendashow.net/episode/1380-transmoney/chapter/jimmy-kimmel-ivermectin-monologue-and-alex-jones.md

Late-night host Jimmy Kimmel's return from hiatus featured a monologue mocking ivermectin users and referencing Alex Jones. The segment notes that Merck, the drug's manufacturer, has issued statements against using ivermectin for COVID-19, likely to protect their upcoming proprietary COVID treatments.

Keywords: [jimmy kimmel](https://search.noagendashow.net/topic/jimmy-kimmel.md), [alex jones](https://search.noagendashow.net/topic/alex-jones.md), [merck](https://search.noagendashow.net/topic/merck.md), [tiktok](https://search.noagendashow.net/topic/tiktok.md), [poison control](https://search.noagendashow.net/topic/poison-control.md)

### Herd Immunity Data, Pfizer's COVID Pill

- **Episode:** [1379: Afghaniscam](https://search.noagendashow.net/episode/1379-afghaniscam.md)
- **Published:** 2021-09-06
- **Time:** 1:02:47–1:06:12
- **Transcript:** https://search.noagendashow.net/episode/1379-afghaniscam/chapter/herd-immunity-data-pfizer-s-covid-pill.md

A study published in JAMA estimates that over 80% of American adults now possess COVID-19 antibodies, a figure traditionally associated with herd immunity. Big Pharma companies like Pfizer and Merck are now shifting focus toward oral therapeutics, such as a "COVID pill," to manage the virus long-term.

Keywords: [jama](https://search.noagendashow.net/topic/jama.md), [antibodies](https://search.noagendashow.net/topic/antibodies.md), [herd immunity](https://search.noagendashow.net/topic/herd-immunity.md), [pfizer](https://search.noagendashow.net/topic/pfizer.md), [merck](https://search.noagendashow.net/topic/merck.md), [therapeutics](https://search.noagendashow.net/topic/therapeutics.md)

### Ivermectin Suppression and Merck Pharmaceutical Competition

- **Episode:** [1361: Variant Factories](https://search.noagendashow.net/episode/1361-variant-factories.md)
- **Published:** 2021-07-04
- **Time:** 39:34–45:20
- **Transcript:** https://search.noagendashow.net/episode/1361-variant-factories/chapter/ivermectin-suppression-and-merck-pharmaceutical-competition.md

Mainstream media outlets and the FDA continue to warn against the use of Ivermectin for COVID-19, often characterizing it solely as a "horse dewormer." Critics suggest this suppression is intended to clear the market for a new, patentable antiviral pill currently under development by Merck. Despite numerous international studies suggesting Ivermectin's efficacy, public health messaging focuses on isolated incidents of improper usage to discourage its adoption.

Keywords: [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [merck](https://search.noagendashow.net/topic/merck.md), [fda](https://search.noagendashow.net/topic/fda.md), [hydroxychloroquine](https://search.noagendashow.net/topic/hydroxychloroquine.md), [clinical trials](https://search.noagendashow.net/topic/clinical-trials.md)

### Dr. Pierre Kory, Ivermectin vs. Patented Drugs

- **Episode:** [1360: Magnetofection](https://search.noagendashow.net/episode/1360-magnetofection.md)
- **Published:** 2021-07-01
- **Time:** 1:06:07–1:08:24
- **Transcript:** https://search.noagendashow.net/episode/1360-magnetofection/chapter/dr-pierre-kory-ivermectin-vs-patented-drugs.md

Dr. Pierre Kory argues that Ivermectin is a highly effective, low-cost treatment for COVID-19 that is being ignored in favor of expensive, patented drugs. He claims that over 100,000 American lives could have been saved if the NIH had adopted Ivermectin protocols earlier.

Keywords: [pierre kory](https://search.noagendashow.net/topic/pierre-kory.md), [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [merck](https://search.noagendashow.net/topic/merck.md), [nih](https://search.noagendashow.net/topic/nih.md), [antiviral](https://search.noagendashow.net/topic/antiviral.md)

### NIH Antiviral Pill Investment, Biden Vaccination Goals

- **Episode:** [1357: Quantum Supremacy](https://search.noagendashow.net/episode/1357-quantum-supremacy.md)
- **Published:** 2021-06-20
- **Time:** 29:34–32:35
- **Transcript:** https://search.noagendashow.net/episode/1357-quantum-supremacy/chapter/nih-antiviral-pill-investment-biden-vaccination-goals.md

The White House and NIH announced a $3.2 billion investment to develop over-the-counter antiviral pills for COVID-19, with Merck expected to be a primary contractor. Meanwhile, President Biden's goal of 70% adult vaccination by July 4th is slipping, with the national rate currently at 65%. Vice President Kamala Harris has framed the vaccination effort in biblical terms, urging citizens to "love thy neighbor."

Keywords: [nih](https://search.noagendashow.net/topic/nih.md), [merck](https://search.noagendashow.net/topic/merck.md), [joe biden](https://search.noagendashow.net/topic/joe-biden.md), [kamala harris](https://search.noagendashow.net/topic/kamala-harris.md), [covid treatment](https://search.noagendashow.net/topic/covid-treatment.md)

### Molnupiravir and the Shift to COVID-19 Antiviral Pills

- **Episode:** [1328: White Adjacent](https://search.noagendashow.net/episode/1328-white-adjacent.md)
- **Published:** 2021-03-11
- **Time:** 50:19–54:32
- **Transcript:** https://search.noagendashow.net/episode/1328-white-adjacent/chapter/molnupiravir-and-the-shift-to-covid-19-antiviral-pills.md

A new oral antiviral drug called Molnupiravir is being positioned as a "Tamiflu for COVID," with early Phase 2 data showing it clears the virus in five days. Dr. Fauci and other researchers suggest that oral drugs are necessary to suppress the virus, similar to treatments for HIV and Hepatitis C. Critics argue that existing, cheaper alternatives like Ivermectin are being ignored in favor of expensive new pharmaceutical products like "COVID-27" preparations.

Keywords: [molnupiravir](https://search.noagendashow.net/topic/molnupiravir.md), [antiviral](https://search.noagendashow.net/topic/antiviral.md), [merck](https://search.noagendashow.net/topic/merck.md), [ivermectin](https://search.noagendashow.net/topic/ivermectin.md), [fauci](https://search.noagendashow.net/topic/fauci.md), covid-27

[Next page](https://search.noagendashow.net/topic/merck.md?offset=20)

---

This is the markdown version of a page on The No Agenda Show for AI agents. Every public page on this site has one: add `.md` to its URL, or request it with `Accept: text/markdown`.

- [Site index for agents (llms.txt)](https://search.noagendashow.net/llms.txt)
- [Home](https://search.noagendashow.net/index.md)
- [Search transcripts](https://search.noagendashow.net/search.md)
- [All episodes](https://search.noagendashow.net/episodes.md)
- [Topics](https://search.noagendashow.net/topics.md)
- [People](https://search.noagendashow.net/people.md)